FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2902517462> ?p ?o ?g. }

• W2902517462 endingPage "8853" @default.
• W2902517462 startingPage "8835" @default.
• W2902517462 abstract "Transcatheter hepatic arterial chemoembolization plus cinobufotalin injection adjuvant therapy for advanced hepatocellular carcinoma: a meta-analysis of 27 trials involving 2,079 patients Na Guo,* Yanyan Miao,* Mingzhong Sun Department of Hepatopathy, The Sixth People’s Hospital of Qingdao, Qingdao 266033, Shandong Province, China *These authors contributed equally to this work Objective: The aim of this study was to systematically investigate the safety and efficacy of the combination of transcatheter hepatic arterial chemoembolization (TACE) and cinobufotalin injection for advanced hepatocellular carcinoma (HC). Methods: Clinical trials were searched from Web of Science, Cochrane Library, PubMed, Embase, Chinese Medical Citation Index (CMCI), China National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), and Wanfang database. Outcome measures including therapeutic efficacy, quality of life, liver function, immune function, and adverse events were extracted and evaluated. Results: After final assessment, 27 studies including 2,079 advanced HC patients were involved in this study. Compared with TACE alone, the combination of TACE with cinobufotalin injection adjuvant therapy significantly prolonged the patients’ 1-, 1.5-, 2-, and 3-year overall survival (OS) rate (1-year OS, OR=2.84, 95% CI=2.20–3.67, P<0.00001; 1.5-year OS, OR=3.57, 95% CI=1.92–6.66, P<0.0001; 2-year OS, OR=3.17, 95% CI=2.36–4.25, P<0.00001; 3-year OS, OR=2.88, 95% CI=1.82–4.57, P<0.00001). The combined therapy also improved patients’ overall response rate (ORR; OR=1.86, 95% CI=1.54–2.24, P<0.00001), disease control rate (DCR; OR=2.05, 95% CI=1.59–2.64, P<0.00001), and quality of life improved rate (QIR; OR=3.45, 95% CI=2.52–4.72, P<0.00001). Moreover, the immune function and liver function of HC patients were all significantly enhanced after the combined therapy of TACE and cinobufotalin injection (CD3+, P=0.001; CD4+, P=0.0006; CD4+/CD8+, P=0.03; natural killer [NK] cell, P=0.01; total bilirubin [TBIL], P=0.003; alanine aminotransferase [ALT], P<0.00001; aspartate aminotransferase [AST], P<0.00001). No serious adverse events occurred during cinobufotalin injection-mediated therapy. Conclusion: The combination of TACE and cinobufotalin injection adjuvant therapy is safe and more effective for end-stage HC treatment than TACE alone. Keywords: hepatocellular carcinoma, cinobufotalin injection, transcatheter hepatic arterial chemoembolization, meta-analysis" @default.
• W2902517462 created "2018-12-11" @default.
• W2902517462 creator A5022252196 @default.
• W2902517462 creator A5025266656 @default.
• W2902517462 creator A5042233884 @default.
• W2902517462 date "2018-12-01" @default.
• W2902517462 modified "2023-10-18" @default.
• W2902517462 title "Transcatheter hepatic arterial chemoembolization plus cinobufotalin injection adjuvant therapy for advanced hepatocellular carcinoma: a meta-analysis of 27 trials involving 2,079 patients" @default.
• W2902517462 cites W1506777089 @default.
• W2902517462 cites W1709885097 @default.
• W2902517462 cites W1981394734 @default.
• W2902517462 cites W1996703005 @default.
• W2902517462 cites W2018527946 @default.
• W2902517462 cites W2028286840 @default.
• W2902517462 cites W2031292021 @default.
• W2902517462 cites W2062009962 @default.
• W2902517462 cites W2068623852 @default.
• W2902517462 cites W2077966066 @default.
• W2902517462 cites W2125763116 @default.
• W2902517462 cites W2272984102 @default.
• W2902517462 cites W2331982648 @default.
• W2902517462 cites W2332171705 @default.
• W2902517462 cites W2561422711 @default.
• W2902517462 cites W2603027791 @default.
• W2902517462 cites W2754440415 @default.
• W2902517462 cites W2755585342 @default.
• W2902517462 cites W2781525129 @default.
• W2902517462 cites W935348974 @default.
• W2902517462 doi "https://doi.org/10.2147/ott.s182840" @default.
• W2902517462 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6290874" @default.
• W2902517462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30573972" @default.
• W2902517462 hasPublicationYear "2018" @default.
• W2902517462 type Work @default.
• W2902517462 sameAs 2902517462 @default.
• W2902517462 citedByCount "11" @default.
• W2902517462 countsByYear W29025174622019 @default.
• W2902517462 countsByYear W29025174622020 @default.
• W2902517462 countsByYear W29025174622021 @default.
• W2902517462 countsByYear W29025174622022 @default.
• W2902517462 crossrefType "journal-article" @default.
• W2902517462 hasAuthorship W2902517462A5022252196 @default.
• W2902517462 hasAuthorship W2902517462A5025266656 @default.
• W2902517462 hasAuthorship W2902517462A5042233884 @default.
• W2902517462 hasBestOaLocation W29025174621 @default.
• W2902517462 hasConcept C126322002 @default.
• W2902517462 hasConcept C143998085 @default.
• W2902517462 hasConcept C197934379 @default.
• W2902517462 hasConcept C2776478404 @default.
• W2902517462 hasConcept C2776694085 @default.
• W2902517462 hasConcept C2777863537 @default.
• W2902517462 hasConcept C2777982462 @default.
• W2902517462 hasConcept C2778019345 @default.
• W2902517462 hasConcept C2778455285 @default.
• W2902517462 hasConcept C2992208098 @default.
• W2902517462 hasConcept C71924100 @default.
• W2902517462 hasConcept C90924648 @default.
• W2902517462 hasConcept C95190672 @default.
• W2902517462 hasConceptScore W2902517462C126322002 @default.
• W2902517462 hasConceptScore W2902517462C143998085 @default.
• W2902517462 hasConceptScore W2902517462C197934379 @default.
• W2902517462 hasConceptScore W2902517462C2776478404 @default.
• W2902517462 hasConceptScore W2902517462C2776694085 @default.
• W2902517462 hasConceptScore W2902517462C2777863537 @default.
• W2902517462 hasConceptScore W2902517462C2777982462 @default.
• W2902517462 hasConceptScore W2902517462C2778019345 @default.
• W2902517462 hasConceptScore W2902517462C2778455285 @default.
• W2902517462 hasConceptScore W2902517462C2992208098 @default.
• W2902517462 hasConceptScore W2902517462C71924100 @default.
• W2902517462 hasConceptScore W2902517462C90924648 @default.
• W2902517462 hasConceptScore W2902517462C95190672 @default.
• W2902517462 hasLocation W29025174621 @default.
• W2902517462 hasLocation W29025174622 @default.
• W2902517462 hasLocation W29025174623 @default.
• W2902517462 hasLocation W29025174624 @default.
• W2902517462 hasLocation W29025174625 @default.
• W2902517462 hasOpenAccess W2902517462 @default.
• W2902517462 hasPrimaryLocation W29025174621 @default.
• W2902517462 hasRelatedWork W2141896878 @default.
• W2902517462 hasRelatedWork W2358577523 @default.
• W2902517462 hasRelatedWork W2360450127 @default.
• W2902517462 hasRelatedWork W2396739986 @default.
• W2902517462 hasRelatedWork W2417110435 @default.
• W2902517462 hasRelatedWork W3013078511 @default.
• W2902517462 hasRelatedWork W3031610734 @default.
• W2902517462 hasRelatedWork W3181754354 @default.
• W2902517462 hasRelatedWork W3194880900 @default.
• W2902517462 hasRelatedWork W4287073673 @default.
• W2902517462 hasVolume "Volume 11" @default.
• W2902517462 isParatext "false" @default.
• W2902517462 isRetracted "false" @default.
• W2902517462 magId "2902517462" @default.
• W2902517462 workType "article" @default.